Goldman benefits from healthcare deal boom

Goldman Sachs, the top healthcare adviser of the year so far, has racked up two more deals worth a total of $2.5bn (€1.9bn) as healthcare dealmaking tripled for the year to date over 2006 figures.

Goldman is advising HealthSouth and Biosite on deals announced yesterday.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump